Financial Results for Quarter Ended June 30, 2026

The Board approved the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27).

Key Financial Figures (INR Lakh, except per share data):

  • Total Income: ₹9.82 (comprising solely Other Income; Net Sales/Income from Operations was nil)
  • Total Expenses: ₹22.86
  • Employee Benefits Expense: ₹0.14
  • Finance Cost: ₹1.50
  • Depreciation and amortisation expenses: ₹7.04
  • Other expenses: ₹14.17
  • Loss before tax: (₹13.04)
  • Tax Expense: (₹6.55) (Deferred tax net)
  • Net Loss for the quarter: (₹6.49)
  • Total Comprehensive Loss: (₹6.49)
  • Paid-up Equity Share Capital: ₹1,639.63 (Face Value ₹10 each)
  • Earnings Per Share (Basic & Diluted): (₹0.04)

Comparative Performance:

  • Net Loss for the previous quarter (Q4 FY26, ended March 31, 2026) was (₹18.20).
  • Net Loss for the corresponding quarter of the previous year (Q1 FY26, ended June 30, 2025) was (₹3.83).
  • For the full year ended March 31, 2026, the company reported a Net Loss of (₹43.22).

The results were reviewed by the Audit Committee and Statutory Auditors (VDP & Co., Chartered Accountants). The financials were prepared under Ind AS.

Management Changes

Based on the recommendation of the Nomination and Remuneration Committee, the Board approved the reappointment of two Independent Directors for a second term of five consecutive years each, subject to shareholder approval via special resolution at the upcoming 34th Annual General Meeting (AGM):

1. Mr. Ramesh Babu Nemani (DIN: 08089820): Reappointment effective from November 15, 2026, to November 14, 2031. He is a Post Graduate in law with a Diploma in Industrial Relations and Personnel Management and has over 25 years of corporate experience.

2. Mr. Sriramshetty Srinivasa Rao (DIN: 00895774): Reappointment effective from November 15, 2026, to November 14, 2031. He is a chemical engineering graduate with 35 years of experience, including as an entrepreneur and consultant.

Both directors are not related to any other directors of the company. Detailed profiles are provided in Annexures A and B.

Other Board Approvals

The Board also approved:

1. The Director's Report along with annexures for the financial year ended March 31, 2026.

2. The notice convening the 34th Annual General Meeting of the company.

Meeting Details

The Board meeting commenced at 5:15 PM and concluded at 6:15 PM on August 10, 2026.